Skip to main content
Log in

Impfung gegen humane Papillomaviren

PATRICIA-Studie (PApilloma TRIal against Cancer In young Adults)

Vaccine against human papillomavirus

PATRICIA Study (PApilloma TRIal against Cancer In young Adults)

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX (2009) HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 115 (Suppl): S15–23

    Article  PubMed  Google Scholar 

  2. FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356: 1915–1927

    Article  Google Scholar 

  3. Pathirana D, Hillemanns P, Petry KU et al. (2009) S3-Leitlinie zur Impfprävention HPV-assoziierter Neoplasien. Chemotherapie J 17:120–171

    Google Scholar 

  4. Robert Koch-Institut (2009) Impfung gegen HPV – Aktuelle Bewertung der STIKO. Epidemiol Bull 32

Download references

Interessenkonflikt

Der Autor hat in den letzten 5 Jahren Berater- und Vortragshonorare von SPMSD und GSK erhalten.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A.M. Kaufmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufmann, A., Nitschmann, S. Impfung gegen humane Papillomaviren. Internist 51, 410–414 (2010). https://doi.org/10.1007/s00108-009-2575-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-009-2575-8

Navigation